Annovazzi and colleagues recently investigated the prognostic value of baseline PET-derived parameter MTV and metabolic response in 57 patients affected by BRAF-mutated melanoma and monitored through 18F-FDG PET/CT during anti BRAF/MEK treatment [40]. Here, BRAF is linked to melanoma.